InvestorsHub Logo

CL101

05/12/17 11:41 AM

#8187 RE: Atlanta1 #8186

come on man, but the value is high..esp. they have the market potential of $15 to $20 billions.

TBRA didn't have the deal like Weigao like amda has.

boston745

05/12/17 11:50 AM

#8188 RE: Atlanta1 #8186

Not a Biotech but not your traditional med device company either. In fact they are now classified as a materials company in their SEC filings.

IMPROVED CERAMIC AND/OR GLASS MATERIALS AND RELATED METHODS

Just look what this WIPO patent can be used for:




Pic 1: Modifying surface chemistry of a Gen 1 SiNi interbody device thus making it Gen 2.
Pic 2: Applying a coating to PEEK implant to give it antibacterial & osteoconductive properties.
Pic 3/4: Coating applied to a femoral stem
Pci 5: Coating applied to pedicle screws.
Pic 6: describes the process of application

This picture shows the result of coating applied to a PEEK implant:


Here is a screenshot of the antibacterial aspects. Notice by 90 days no presence of bacteria was found around the implant after purposefully inoculating it. Infections from surgeries cost US healthcare system between 36-45 billion annually.